Seeking Alpha

Cardiovascular Systems (CSII +15%) gains today after reporting a better-than-expected Q2 net...

Cardiovascular Systems (CSII +15%) gains today after reporting a better-than-expected Q2 net loss of $0.28 per share, $0.05 wider than a year ago but nonetheless beating analyst expectations. Revenue climbed 28% Y/Y, as conversions to the company's Stealth 360 treatment for peripheral artery disease continued at a high rate, representing 93% of total device revenues for the quarter. Revenue from office-based labs also climbed at a double-digit pace.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|